1. Home
  2. HLMN vs NTLA Comparison

HLMN vs NTLA Comparison

Compare HLMN & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$8.98

Market Cap

1.8B

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$9.17

Market Cap

986.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
NTLA
Founded
1964
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
986.9M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
HLMN
NTLA
Price
$8.98
$9.17
Analyst Decision
Buy
Buy
Analyst Count
6
22
Target Price
$12.20
$19.83
AVG Volume (30 Days)
984.6K
3.6M
Earning Date
02-17-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
388.43
N/A
EPS
0.19
N/A
Revenue
$1,536,647,000.00
$57,528,000.00
Revenue This Year
$7.97
$1.96
Revenue Next Year
$7.80
N/A
P/E Ratio
$47.85
N/A
Revenue Growth
4.47
33.52
52 Week Low
$6.55
$5.90
52 Week High
$10.64
$28.25

Technical Indicators

Market Signals
Indicator
HLMN
NTLA
Relative Strength Index (RSI) 50.73 43.15
Support Level $8.81 $8.74
Resistance Level $9.11 $9.62
Average True Range (ATR) 0.24 0.47
MACD 0.01 0.24
Stochastic Oscillator 46.51 36.04

Price Performance

Historical Comparison
HLMN
NTLA

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: